Changes in patient-reported outcomes with etanercept treatment following apremilast failure in patients with moderate to severe psoriasis

被引：0
|
作者：
Bagel, Jerry [1 ]
Stolshek, Bradley S. [2 ]
Samad, Ahmed S. [2 ]
Yang, Yue [2 ]
Chung, James B. [2 ]
Kricorian, Gregory [2 ]
Kircik, Leon [3 ]
机构：
[1] Psoriasis Treatment Ctr Cent New Jersey, East Windsor, NJ USA
[2] Amgen Inc, Thousand Oaks, CA 91320 USA
[3] DermResearch PLLC, Louisville, KY USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2019年 / 81卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
9693
引用
收藏
页码：AB180 / AB180
页数：1
相关论文
共 50 条
  • [1] Treatment with etanercept improves patient-reported outcomes in patients with moderate to severe psoriasis
    Gottlieb, A
    Woolley, JM
    Lalla, D
    Jahreis, A
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P201 - P201
  • [2] Evaluation of Patient-Reported Outcomes With Etanercept in Moderate to Severe Plaque Psoriasis Patients After Therapy With Apremilast
    Bagel, Jerry
    Stolshek, Bradley S.
    Yang, Yue
    Kricorian, Gregory
    Kircik, Leon H.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2020, 19 (04) : 378 - 383
  • [3] Clinically meaningful improvements in patient-reported outcomes for patients with moderate to severe psoriasis receiving etanercept
    Krueger, G
    Woolley, J
    Zitnik, R
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (03) : A55 - A55
  • [4] Sustained improvement in patient-reported outcomes with continued apremilast treatment over 104 weeks in patients with moderate to severe psoriasis
    Chapman, M.
    Cirulli, J.
    McBride, S.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2018, 59 : 46 - 46
  • [5] Effect of apremilast on patient-reported outcomes in patients with moderate to severe plaque psoriasis in the ESTEEM 1 trial
    Armstrong, April
    Griffiths, Christopher
    Tencer, Tom
    Li, Stan
    Zhang, Frank
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB231 - AB231
  • [6] Effect of apremilast on patient-reported outcomes in patients with moderate to severe plaque psoriasis in the ESTEEM 1 trial
    Armstrong, A. W.
    Griffiths, C.
    Tencer, T.
    Li, S.
    Zhang, F.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 : 67 - 67
  • [7] The effects of etanercept therapy on patient reported outcomes for patients with moderate to severe psoriasis
    Krueger, GG
    Woolley, JM
    Zitnik, R
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P155 - P155
  • [8] Characterization of Patient-reported Outcomes in moderate to severe Psoriasis
    Radtke, M. A.
    Schmitt-Rau, K. H.
    Krenzer, S.
    Augustin, M.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 126 - 126
  • [9] Characterization of Patient-Reported Outcomes in Moderate to Severe Psoriasis
    Krenzer, Stefanie
    Radtke, Marc
    Schmitt-Rau, Karlheinz
    Augustin, Matthias
    DERMATOLOGY, 2011, 223 (01) : 80 - 86
  • [10] Patient-reported treatment satisfaction in moderate to severe plaque psoriasis
    Brenneman, Susan
    Carter, Chureen
    Essoi, Breanna
    Farahi, Kamyar
    Johnson, Michael P.
    Lee, Seina
    Olson, William
    Zhang, Mingliang
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB242 - AB242
12345